Uroflowmetric assessment of acute effects of sildenafil on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia

被引:22
作者
Guven, Esref O. [1 ]
Balbay, Mevlana D. [1 ]
Mete, Kilciler [2 ]
Serefoglu, Ege C. [3 ]
机构
[1] Mustafa Kemal Univ, Dept Urol, Antakya, Turkey
[2] Gulhane Mil Med Acad, Ankara, Turkey
[3] Ankara Ataturk Res Hosp, Dept Urol, Ankara, Turkey
关键词
Benign prostate hyperplasia; Lower urinary tract symptoms; Phosphodiesterase inhibitors; Sildenafil; Uroflowmetry; URINARY-TRACT SYMPTOMS; SMOOTH-MUSCLE; CITRATE; PHOSPHODIESTERASES; INHIBITORS; BLADDER; CELLS;
D O I
10.1007/s11255-008-9423-y
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the acute effects of sildenafil (50 mg) on the micturation of men with erectile dysfunction (ED) and concomitant benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS) using uroflowmetric parameters. A total of 68 male patients randomized into two groups (36 treatment, 32 control groups) with International Prostate Symptom Score (IPSS) greater than 7 and International Index of Erectile Dysfunction-erectile function domain score lower than 26 were enrolled in the study. Patients in the treatment group received a single dose of 50 mg of oral sildenafil. Patients in the control group received no treatment. Prevoiding urine volumes determined ultrasonographically and voided urine volumes were also recorded. Statistical comparisons were made with the use of analysis of variance (ANOVA). Mean ages were similar between treatment and control groups (60.4 +/- A 9.8 and 58.6 +/- A 8.3 years, respectively, P = 0.430). In the treatment group the maximum and average flow rates increased significantly (Q (max) from 15.6 +/- A 6.8 cc/s to 19.3 +/- A 7.2 cc/s, P < 0.0001; Q (avg) from 7.3 +/- A 3.0 cc/s to 9.1 +/- A 3.0 cc/s, P < 0.0001) with sildenafil administration, while other parameters studied remained unchanged. Despite the limitations of variations of uroflowmetry, this study showed that sildenafil improves Q (max) and Q (avg) in patients suffering from ED with concomitant BPH-LUTS. Long-term studies are needed to evaluate the effects on IPSS, side effects, and drug interactions.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 24 条
[1]   Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: Sildenafil and papaverin generate inhibition [J].
Adolfsson, PI ;
Ahlstrand, C ;
Varenhorst, E ;
Svensson, SPS .
PROSTATE, 2002, 51 (01) :50-58
[2]   Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS [J].
Andersson, Karl-Erik ;
Uckert, Stefan ;
Stief, Christian ;
Hedlund, Petter .
NEUROUROLOGY AND URODYNAMICS, 2007, 26 (06) :928-933
[3]   Lower urinary tract symptoms and erectile dysfunction: Co-morbidity or typical "aging male" symptoms? Results of the "Cologne male survey [J].
Braun, MH ;
Sommer, F ;
Haupt, G ;
Mathers, MJ ;
Reifenrath, B ;
Engelmann, UH .
EUROPEAN UROLOGY, 2003, 44 (05) :588-594
[4]   Isolation and chiral GC analysis of β-bisabolols -: Trace constituents from the essential oil of Santalum album L. (Santalaceae) [J].
Braun, NA ;
Meier, M ;
Pickenhagen, W .
JOURNAL OF ESSENTIAL OIL RESEARCH, 2003, 15 (02) :63-65
[5]   Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction [J].
Chang, SH ;
Hypolite, JA ;
Zderic, SA ;
Wein, AJ ;
Chacko, S ;
DiSanto, ME .
JOURNAL OF UROLOGY, 2002, 167 (06) :2636-2644
[6]   Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells [J].
Cook, ALM ;
Haynes, JM .
CELLULAR SIGNALLING, 2004, 16 (02) :253-261
[7]   Characterization and functional role of androgen-dependent PDE5 activity in the bladder [J].
Filippi, Sandra ;
Morelli, Annamaria ;
Sandner, Peter ;
Fibbi, Benedetta ;
Mancina, Rosa ;
Marini, Mirca ;
Gacci, Mauro ;
Vignozzi, Linda ;
Vannelli, Gabriella Barbara ;
Carini, Marco ;
Forti, Gianni ;
Maggi, Mario .
ENDOCRINOLOGY, 2007, 148 (03) :1019-1029
[8]   Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil [J].
Haaga, J. R. ;
Exner, A. ;
Fei, B. W. ;
Seftel, A. D. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (01) :110-113
[9]   The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: An overview [J].
Hieble, JP ;
Ruffolo, RR .
PHARMACOLOGICAL RESEARCH, 1996, 33 (03) :145-160
[10]  
Kaplan Steven A, 2007, Rev Urol, V9, P73